Skip to main content

Advertisement

Log in

Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

In our previous study, Human Signal Transduction in Cancer Gene Array was used in 12 fresh tumor samples to detect the gene expression profiles in the esophageal squamous cell carcinoma (ESCC) tissues matched adjacent non-cancerous samples. Among genes up-regulated at least twofold, β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 were found. So subsequently, the aim of this study was to investigate the prognosis and clinicopathologic roles of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 in ESCC tissue. The mRNA and protein expression levels of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 genes in 70 ESCC and adjacent non-cancerous paraffin-embedded samples were determined by Real-Time Quantitative PCR (RT-PCR) and immunohistochemical staining. The mRNA expression level of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 in ESCC was significantly higher than that in the adjacent non-cancerous tissues (0.0821 ± 0.0416 vs. 0.0185 ± 0.0201, P = 0.0000; 1.9934 ± 1.9888 vs. 0.8863 ± 0.665, P = 0.0184; 0.0298 ± 0.0215 vs. 0.0189 ± 0.0187, P = 0.0017; 2.098 ± 0.091 vs. 1.016 ± 0.078, P = 0.0000; 2.181 ± 2.158 vs. 0.931 ± 0.894, P = 0.0152; respectively), and the protein expression level of determined genes was also significantly higher than that in the adjacent non-cancerous tissues (0.2835 ± 0.0844 vs. 0.2352 ± 0.0670, P = 0.0003; 0.3830 ± 0.0947 vs. 0.2721 ± 0.1474, P = 0.0000; 0.2637 ± 0.0348 vs. 0.2042 ± 0.0180, P = 0.0000; 0.2058 ± 0.0316 vs. 0.1218 ± 0.0518, P = 0.0000; 0.2736 ± 0.0834 vs. 0.2251 ± 0.0571, P = 0.0001; respectively). Then, the overexpression of mRNA and protein levels of β-catenin, Wnt1 and Bmi-1 was aggressively associated with lymph node metastasis, advanced pathological stage, and prognosis of the patients with ESCC (P < 0.05). The up-expression of Hoxa9 mRNA and protein was also aggressively associated with lymph node metastasis and advanced pathological stage (P < 0.05); however, the overexpression of Hoxa9 protein was not associated with the prognosis (P > 0.05). Meanwhile, the hypo-expression of Smad4 mRNA was aggressively associated with advanced pathological stage and prognosis of the patients with ESCC (P < 0.05); however, the hypo-expression of Smad4 protein was neutral to the prognosis and lymph node metastasis (P > 0.05). β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 protein expression analysis showed that the positive outcomes of the combined detection of Wnt1 and β-catenin expression or Wnt1, β-catenin and Bmi-1 expression were significantly worse than those of a single target protein expression (P < 0.05). Meantime, the prognosis of the combined positive expression of Wnt1, β-catenin, and Bmi-1 was poorer than that in the combined positive expression of Wnt1 and β-catenin (P < 0.05). The prognosis of ESCC patients with the overexpression of Wnt1/β-catenin and Bmi-1 was relatively poor, and the level of Wnt1/β-catenin and Bmi-1 was conversely correlated with advanced pathological stage and lymph node metastasis. The expression level of Smad4 and Hoxa9 mRNA was also associated with the prognosis of the patients with ESCC, pathological stage, and lymph node metastasis; however, they might not be the independent prognostic factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Piero Marco Fisichella and Marco G Patti. Esophageal Cancer. eMedicine: Oncology, Aug 26, 2008-08-26. http://emedicine.medscape.com/article/277930-overview

  2. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. p. 91–8.

    Google Scholar 

  3. James RG, Conrad WH, Moon RT. Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods Mol Biol. 2008;468:131–44.

    Article  PubMed  CAS  Google Scholar 

  4. Corrigan PM, Dobbin E, Freeburn RW, et al. Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. Stem Cells Dev. 2009;18:759–72.

    Article  PubMed  CAS  Google Scholar 

  5. Fillmore RA, Mitra A, Xi Y, et al. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer. 2009;125:556–64.

    Article  PubMed  CAS  Google Scholar 

  6. Matsubayashi S, Nakashima M, Kumagai K, et al. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Pathol Res Pract. 2009;205:626–33.

    Article  PubMed  Google Scholar 

  7. Clifford RL, Deacon K, Knox AJ. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, and GSK3 (beta). J Biol Chem. 2008;283:35337–53.

    Article  PubMed  CAS  Google Scholar 

  8. Tian X, Du H, Fu X, Li K, et al. Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells. Biochem Biophys Res Commun. 2009;380:478–83.

    Article  PubMed  CAS  Google Scholar 

  9. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5:997–1014.

    Article  PubMed  CAS  Google Scholar 

  10. Dihlmann S, von Knebel Doeberitz M. Wnt/-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer. 2005;113:515–24.

    Article  PubMed  CAS  Google Scholar 

  11. Huang M, Wang Y, Sun D, et al. Identification of genes regulated by Wnt/β-catenin pathway and involved in apoptosis via microarray analysis. BMC Cancer. 2006;6:221.

    Article  PubMed  Google Scholar 

  12. Winkel A, Stricker S, Tylzanowski P, et al. Wnt-ligand-dependent interaction of TAK1 (TGF-beta-activated kinase-1) with the receptor tyrosine kinase Ror2 modulates canonical Wnt-signalling. Cell Signal. 2008;20:2134–44.

    Article  PubMed  CAS  Google Scholar 

  13. Verkaar F, van Rosmalen JW, Smits JF, et al. Stably overexpressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2+-mobilization in Human Embryonic Kidney 293 cells. Cell Signal. 2009;21:22–33.

    Article  PubMed  CAS  Google Scholar 

  14. Lyu J, Yamamoto V, Lu W. Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell. 2008;15:773–80.

    Article  PubMed  CAS  Google Scholar 

  15. Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007;13:4042–5.

    Article  PubMed  CAS  Google Scholar 

  16. Paul S, Dey A. Wnt signaling and cancer development: therapeutic implication. Nat Rev Genet. 2008;55:165–76.

    CAS  Google Scholar 

  17. Herbst A, Kolligs FT. Wnt signaling as a therapeutic target for cancer. Methods Mol Biol. 2007;361:63–91.

    PubMed  CAS  Google Scholar 

  18. Mizushima T, Nakagawa H, Kamberov YG, et al. Wnt-1 but not epidermal growth factor induces β-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 2002;62:277–82.

    PubMed  CAS  Google Scholar 

  19. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M, et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (Lond). 1999;397:164–8.

    Article  CAS  Google Scholar 

  20. Nakanishi Y, Ochiai A, Akimoto S, et al. Expression of E-cadherin, apha - catenin, beta - catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology. 1997;54:158–65.

    Article  PubMed  CAS  Google Scholar 

  21. Krishnadath KK, Tilanus HW, Blankenstein MV, et al. Reduced expression of the cadherin—catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol. 1997;2:331–8.

    Article  Google Scholar 

  22. Osterheld MC, Bian YS, Bosman FT, et al. Beta—catenin expression and its association with prognostic factors in adenocarcinoma developed in Brrett esophagus. Am J Clin Pathol. 2002;117:451–6.

    Article  PubMed  CAS  Google Scholar 

  23. Yanagiswa J, Yanagi Y, Masuhire Y. Convergenece of transforming growth factor-p and vitamin D signaling pathways on SMAD transcriptional coactivators. Science. 1999;283:l3l7–21.

    Google Scholar 

  24. Fukuchi M, Masuda N, Miyazaki T, et al. Decreased Smad4 expression in the transforming growth factor-β signaling pathway during progression of esophageal squamous cell carcinoma. Cancer. 2002;95:737–43.

    Article  PubMed  CAS  Google Scholar 

  25. Takahashi O, Hamada J-I, Abe M, et al. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncology Reports. 2007;17:753–60.

    PubMed  CAS  Google Scholar 

  26. Cillo C, Barba P, Freschi G, et al. HOX gene expression in normal and neoplastichuman kidney. Int J Cancer. 1992;51:892–7.

    Article  PubMed  CAS  Google Scholar 

  27. De Vita G, Barba P, Odartchenko N, et al. Expressionof homeobox-containing genes in primary and metastaticcolorectal cancer. Eur J Cancer. 1993;29A:887–93.

    PubMed  Google Scholar 

  28. Cantile M, Cindolo L, Napodano G, et al. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene. 2003;22:6462–8.

    Article  PubMed  CAS  Google Scholar 

  29. Waltregny D, Alami Y, Clausse N, et al. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate. 2002;50:162–9.

    Article  PubMed  CAS  Google Scholar 

  30. Hamada J, Omatsu T, Okada F, et al. Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis- related genes in human lung cancer cells. Int J Cancer. 2001;93:516–25.

    Article  CAS  Google Scholar 

  31. Maeda K, Hamada J, Takahashi Y, et al. Altered expressions of HOX genes in human cutaneous malignant melanoma. Int J Cancer. 2005;114:436–41.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Supported by Affiliated Nanjing First Hospital, Nanjing Medical University and Nanjing Health Bureau, No. ZKX0114.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jin Lv.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lv, J., Cao, XF., Ji, L. et al. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Med Oncol 29, 151–160 (2012). https://doi.org/10.1007/s12032-010-9816-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9816-5

Keywords

Navigation